MapLight Therapeutics Inc
MPLT20.440USD
+1.590+8.44%
Market hours （ET）Quotes delayed by 15 min
846.81MMarket Cap
LossP/E TTM
More Details of Company
MapLight Therapeutics Inc Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of MapLight Therapeutics Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
296.01K
--
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Chief Accounting Officer, Chief Administrative Officer
Chief Accounting Officer, Chief Administrative Officer
270.55K
--
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
82.72K
--
Mr. Vishwas Setia
Mr. Vishwas Setia
Chief Financial Officer
Chief Financial Officer
51.19K
--
Dr. Timothy Garnett
Dr. Timothy Garnett
Independent Director
Independent Director
9.48K
--
Mr. Jim Trenkle, Ph.D.
Mr. Jim Trenkle, Ph.D.
Independent Director
Independent Director
--
--
Mr. George Pavlov
Mr. George Pavlov
Independent Director
Independent Director
--
--
Mr. Robert Malenka, M.D., Ph.D.
Mr. Robert Malenka, M.D., Ph.D.
Director
Director
--
--
Mr. James Lillie, Ph.D.
Mr. James Lillie, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Christopher A. Kroeger, M.D.
Dr. Christopher A. Kroeger, M.D.
Co-Founder, President, Chief Executive Officer, Director
Co-Founder, President, Chief Executive Officer, Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
296.01K
--
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Chief Accounting Officer, Chief Administrative Officer
Chief Accounting Officer, Chief Administrative Officer
270.55K
--
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
82.72K
--
Mr. Vishwas Setia
Mr. Vishwas Setia
Chief Financial Officer
Chief Financial Officer
51.19K
--
Dr. Timothy Garnett
Dr. Timothy Garnett
Independent Director
Independent Director
9.48K
--
Mr. Jim Trenkle, Ph.D.
Mr. Jim Trenkle, Ph.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: 19 hours ago
Updated: 19 hours ago
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Catalyst4 Inc
43.41%
Novo Holdings A/S
8.13%
Forbion Growth Opportunities Fund III Cooperatief UA
3.14%
Kroeger (Christopher A. M.D.)
1.01%
Lillie (James Woodruff)
0.74%
Other
43.57%
Shareholders
Shareholders
Proportion
Catalyst4 Inc
43.41%
Novo Holdings A/S
8.13%
Forbion Growth Opportunities Fund III Cooperatief UA
3.14%
Kroeger (Christopher A. M.D.)
1.01%
Lillie (James Woodruff)
0.74%
Other
43.57%
Shareholder Types
Shareholders
Proportion
Corporation
46.56%
Venture Capital
8.13%
Individual Investor
4.20%
Other
41.12%
Institutional Shareholding
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
1
3.69M
8.13%
+3.69M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
No Data
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of MapLight Therapeutics Inc?
The top five shareholders of MapLight Therapeutics Inc are:
What are the top three shareholder types of MapLight Therapeutics Inc?
The top three shareholder types of MapLight Therapeutics Inc are:
Catalyst4 Inc
Novo Holdings A/S
Forbion Growth Opportunities Fund III Cooperatief UA
Catalyst4 Inc
Novo Holdings A/S
Forbion Growth Opportunities Fund III Cooperatief UA
How many institutions hold shares of MapLight Therapeutics Inc (MPLT)?
As of 2025Q4, 1 institutions hold shares of MapLight Therapeutics Inc, with a combined market value of approximately 3.69M, accounting for 8.13% of the total shares. Compared to --, institutional shareholding has increased by --.
What is the biggest source of revenue for MapLight Therapeutics Inc?
In --, the -- business generated the highest revenue for MapLight Therapeutics Inc, amounting to -- and accounting for --% of total revenue.
